TMX2 enhances hepatocellular carcinoma (HCC) cell viability by promoting autophagy and mitophagy, is upregulated in HCC tissues, associated with poor prognosis, and potentially serves as a therapeutic target. This evidence concerns the gene TMX2 and hepatocellular carcinoma.